Cybin Inc. (HELP) vs Kura Oncology, Inc. (KURA)
Cybin Inc. and Kura Oncology, Inc. are both Biotechnology companies. Cybin Inc. and Kura Oncology, Inc. are of similar size ($977.7M and $926.4M). Cybin Inc. has the higher net margin (0.00% vs −384.3%) and the lower return on invested capital (−137.9% vs 0.00%). Across the 14 metrics below, Cybin Inc. leads on 9 and Kura Oncology, Inc. on 5.
Valuation
Profitability
| Metric | HELP | KURA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.35% | 65.16% |
| Operating margin | 0.00% | (411.90%) | 0.00% |
| Net margin | 0.00% | (384.30%) | 0.00% |
| Free cash flow margin | 0.00% | (152.06%) | 0.00% |
| Return on equity | (86.94%) | (167.71%) | (57.72%) |
| Return on assets | (72.78%) | (46.73%) | (49.22%) |
| Return on invested capital | (137.88%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack